Walker Karen Marie
Chief Technology Officer
Walker Karen Marie has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 17, 2025.
On the most recent filing, Walker Karen Marie is listed as Chief Technology Officer at Kyverna Therapeutics, Inc. Inside the rolling window, Walker Karen Marie reported no open-market purchases and 1 open-market sale totaling $293K in KYTX.
Companies traded
Other insiders at KYTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$293K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Walker Karen Marie made?
Walker Karen Marie has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2025.
Which companies does Walker Karen Marie trade?
Walker Karen Marie has filed SEC Form 4 disclosures for 1 company, including KYTX.
When was Walker Karen Marie's most recent SEC Form 4 filing?
Walker Karen Marie's most recent SEC Form 4 filing on Tracefour is dated Dec 17, 2025.
What is Walker Karen Marie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Walker Karen Marie is listed as Chief Technology Officer.
What is Walker Karen Marie's total buy and sell value in the current window?
Inside the rolling retention window, Walker Karen Marie bought $0 and sold $293K based on SEC Form 4 filings.
What was Walker Karen Marie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 23,998 KYTX shares on 2025-12-15, worth $293K, per SEC Form 4 filings.